Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Amgen vs. Mirati Therapeutics


Investors looking for biotech stocks to buy will notice lots of buzz around Amgen (NASDAQ: AMGN) and Mirati Therapeutics (NASDAQ: MRTX) lately. Both companies are developing similar new cancer treatments that could go on to generate billions in annual sales, and there are plenty of arguments over which company has the best one.

Which one of these stocks is a better fit for your portfolio? Let's have a look at the case for each to weigh their chances to provide outsize returns.  

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments